Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 2 11Phase 3 2Phase 4 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Stomach Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Parathyroid Diseases 1Ovarian Neoplasms 1Osteosarcoma 1Neuroma 1Neoplasms 1Lymphatic Metastasis 1Hypoparathyroidism 1Graves Disease 1Goiter 1Giant Cell Tumor of Tendon Sheath 1Giant Cell Tumor of Bone 1Erectile Dysfunction 1Endometrial Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Anastomotic Leak 1Adenoma 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Indocyanine Green × Clear all
NCT02781259 2016-09-20

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

Samsung Medical Center

Phase 4 Unknown
150 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡